Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yannick Allanore

Showing results (341-350 of 448) with videos related to

Pageof 45
Sort By:
Journal of Autoimmunity|March 4, 2025
Total lung capacity is predictive of disease severity and survival in systemic sclerosis: A longitudinal analysis in 2347 patients from the French National Cohort StudyBenjamin Chaigne, Alexandre Bense, Frédérique Aubourg, et al.
Seminars in Arthritis and Rheumatism|October 1, 2023
Non-surgical local treatments of digital ulcers in systemic sclerosis: a systematic literature reviewCorrado Campochiaro, Yossra A Suliman, Michael Hughes, et al.
Rheumatology (Oxford, England)|June 19, 2023
Systemic pharmacological treatment of digital ulcers in systemic sclerosis: a systematic literature reviewLaura Ross, Nancy Maltez, Michael Hughes, et al.
Annals of the Rheumatic Diseases|March 18, 2026
Risk score for early mortality to stratify for intensive SSc therapy in the EUSTAR network: the RESIST scoreAnn-Christin Pecher, Marouane Boubaya, Yannick Allanore, et al.
Seminars in Arthritis and Rheumatism|October 12, 2023
Surgical management of digital ulcers in systemic sclerosis: A systematic literature reviewYossra A Suliman, Corrado Campochiaro, Michael Hughes, et al.
Annals of the Rheumatic Diseases|May 1, 2020
Systemic sclerosis and the COVID-19 pandemic: World Scleroderma Foundation preliminary advice for patient managementMarco Matucci-Cerinic, Cosimo Bruni, Yannick Allanore, et al.
Human Mutation|May 12, 2011
Clinical and biochemical heterogeneity associated with fumarase deficiencyChris Ottolenghi, Laurence Hubert, Yannick Allanore, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 15, 2016
OX40L blockade protects against inflammation-driven fibrosisMuriel Elhai, Jérôme Avouac, Anna Maria Hoffmann-Vold, et al.
Journal of Scleroderma and Related Disorders|July 28, 2021
Considerations for a combined index for limited cutaneous systemic sclerosis to support drug development and improve outcomesAlain Lescoat, Susan L Murphy, David Roofeh, et al.
Autoimmunity Reviews|February 25, 2026
Points to consider for reporting digital ulcers in systemic sclerosis interventional studies: An initiative from the world Scleroderma Foundation digital ulcer ad hoc committeeCorrado Campochiaro, Nancy Maltez, Yossra Suliman, et al.
Pageof 45

Showing results (341-350 of 448) with videos related to

Sort By:
Pageof 45
Journal of Autoimmunity|March 4, 2025
Total lung capacity is predictive of disease severity and survival in systemic sclerosis: A longitudinal analysis in 2347 patients from the French National Cohort StudyBenjamin Chaigne, Alexandre Bense, Frédérique Aubourg, et al.
Seminars in Arthritis and Rheumatism|October 1, 2023
Non-surgical local treatments of digital ulcers in systemic sclerosis: a systematic literature reviewCorrado Campochiaro, Yossra A Suliman, Michael Hughes, et al.
Rheumatology (Oxford, England)|June 19, 2023
Systemic pharmacological treatment of digital ulcers in systemic sclerosis: a systematic literature reviewLaura Ross, Nancy Maltez, Michael Hughes, et al.
Annals of the Rheumatic Diseases|March 18, 2026
Risk score for early mortality to stratify for intensive SSc therapy in the EUSTAR network: the RESIST scoreAnn-Christin Pecher, Marouane Boubaya, Yannick Allanore, et al.
Seminars in Arthritis and Rheumatism|October 12, 2023
Surgical management of digital ulcers in systemic sclerosis: A systematic literature reviewYossra A Suliman, Corrado Campochiaro, Michael Hughes, et al.
Annals of the Rheumatic Diseases|May 1, 2020
Systemic sclerosis and the COVID-19 pandemic: World Scleroderma Foundation preliminary advice for patient managementMarco Matucci-Cerinic, Cosimo Bruni, Yannick Allanore, et al.
Human Mutation|May 12, 2011
Clinical and biochemical heterogeneity associated with fumarase deficiencyChris Ottolenghi, Laurence Hubert, Yannick Allanore, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 15, 2016
OX40L blockade protects against inflammation-driven fibrosisMuriel Elhai, Jérôme Avouac, Anna Maria Hoffmann-Vold, et al.
Journal of Scleroderma and Related Disorders|July 28, 2021
Considerations for a combined index for limited cutaneous systemic sclerosis to support drug development and improve outcomesAlain Lescoat, Susan L Murphy, David Roofeh, et al.
Autoimmunity Reviews|February 25, 2026
Points to consider for reporting digital ulcers in systemic sclerosis interventional studies: An initiative from the world Scleroderma Foundation digital ulcer ad hoc committeeCorrado Campochiaro, Nancy Maltez, Yossra Suliman, et al.
Pageof 45